Company: EUDAW
Filing Date: 2025-12-04
Form Type: 424B5
Source: 0001493152-25-026224
Chunk: 21

Company: EUDA Health Holdings Ltd
Filing Date: 2025-12-04
Form: 424B5
Chunk 21
---
 or proportionately decreased in the case of a combination. Appropriate adjustments shall also be made to the Exercise Price and other applicable amounts, but the aggregate purchase price payable for the total number of Warrant Shares purchasable under the Warrant (as adjusted) shall remain the same.

Governing Law

The Warrant is governed by and construed the internal laws of the State of Utah.

Description of Ordinary Shares

The material terms and provisions of our Ordinary Shares are described under the caption “Description of Securities” beginning on page 9 of the accompanying base prospectus.

We are authorized to issue unlimited number of ordinary shares with no par value each.

As of the date of this prospectus supplement, there were 37,807,491 ordinary shares outstanding.

| S-14 |

<div align='center'>CAPITALIZATION</div>

The following table sets forth our capitalization as of June 30, 2025:

|                                                                                                                                                          |     | As of June 30, 2025 |             |   |     |             |            |   |     |                       |             |   |
|:---------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:--------------------|------------:|:--|:----|:------------|-----------:|:--|:----|:----------------------|------------:|:--|
|                                                                                                                                                          |     | Actual              |             |   |     | As Adjusted 
 (unaudited) |            |   |     | Pro forma as Adjusted 
 (unaudited)           |             |   |
| Shareholders’ Equity                                                                                                                                     |     |                     |             |   |     |             |            |   |     |                       |             |   |
| Ordinary shares, unlimited authorized, 37,156,382 shares issued and outstanding, actual and 39,807,491 shares issued and outstanding, pro forma adjusted |     |                     |  47,829,228 |   |     |             | 12,100,000 |   |     |                       |  59,929,228 |   |
| Accumulated deficit                                                                                                                                      |     |                     | (51,304,427 | ) |     |             |    (82,500 | ) |     |                       | (51,386,927 | ) |
| Accumulated other comprehensive loss                                                                                                                     |     |                     |    (234,366 | ) |     |             |          - |   |     |                       |    (234,366 | ) |
| Total shareholders